300
Participants
Start Date
June 30, 2003
Study Completion Date
April 30, 2004
sildenafil
sildenafil 50 mg (initial dose) tablet by mouth 30 to 60 minutes prior to sexual activity for 12 weeks; depending upon safety, efficacy and tolerability, the dose could be increased to 100 mg or reduced to 25 mg, if necessary.
placebo
placebo tablet by mouth 30 to 60 minutes prior to sexual activity for 12 weeks
Pfizer Investigational Site, New York
Pfizer Investigational Site, New York
Pfizer Investigational Site, Garden City
Pfizer Investigational Site, Poughkeepsie
Pfizer Investigational Site, Newtown
Pfizer Investigational Site, Baltimore
Pfizer Investigational Site, Durham
Pfizer Investigational Site, Ocala
Pfizer Investigational Site, Huntsville
Pfizer Investigational Site, Knoxville
Pfizer Investigational Site, Jeffersonville
Pfizer Investigational Site, Des Moines
Pfizer Investigational Site, Peoria
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Overland Park
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Beverly Hills
Pfizer Investigational Site, Torrance
Pfizer Investigational Site, Laguna Woods
Pfizer Investigational Site, Palo Alto
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Lacey
Pfizer Investigational Site, Spokane
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Waterbury
Pfizer Investigational Site, Peabody
Pfizer Investigational Site, Beachwood
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY